Skip to main content

Table 2 Relative risks of cancer progression for low, intermediate and high risk cancer compared to all localised prostate cancer patients in the SPCG-4 study

From: The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer

Relative risk

Risk group

Mean

SE

Distribution

In the radical prostatectomy arm

 RR_lowrisk_WW

Low risk

0.2947

0.0100

Gamma

 RR_intermrisk_WW

Intermediate risk

1.0397

0.0347

Gamma

 RR_highrisk_WW

High risk

1.9600

0.0655

Gamma

In the watchful waiting arm

 RR_lowrisk_RP

Low risk

0.3006

0.0107

Gamma

 RR_intermrisk_RP

Intermediate risk

1.0606

0.0374

Gamma

 RR_highrisk_RP

High risk

1.9993

0.0703

Gamma

  1. RR relative risk, RP radical prostatectomy, AS active surveillance, WW watchful waiting RR_lowrisk_WW: relative risk of cancer progression for low risk patients compared to localised prostate cancer patients in the watchful waiting arm